Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Osteopore Ltd. ( (AU:OSX) ) is now available.
Osteopore Limited announced several strategic partnerships to enhance its position in the regenerative medicine market. The company signed agreements with RxCell and CytoMed, expanding into the scaffold-based therapy market and advancing MSC-powered regeneration, respectively. Additionally, the company engaged with scientists to innovate in regenerative medicine, marking a significant step in its operational growth and potential market impact.
More about Osteopore Ltd.
Osteopore Limited is a company in the regenerative medicine industry, specializing in the manufacture of regenerative implants that facilitate natural tissue regeneration. The company is focused on expanding its market presence in the scaffold-based therapy sector.
YTD Price Performance: -15.00%
Average Trading Volume: 201,398
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$3.97M
See more data about OSX stock on TipRanks’ Stock Analysis page.